Eton Pharmaceuticals

ETONEton Pharmaceuticals

About Eton Pharmaceuticals

Eton Pharmaceuticals (NASDAQ:ETON) specializes in developing, acquiring, and marketing a broad range of pharmaceutical products with a focus on rare diseases and hospital-based conditions. The company aims to bring innovative treatments to market that can significantly improve patients' lives, particularly in areas where there are few or no existing therapeutic options. With a commitment to excellence in pharmaceutical development, Eton Pharmaceuticals continuously seeks new projects and opportunities to expand its portfolio of products. The goal is to address unmet medical needs and offer better health solutions through its specialized and effective pharmaceutical offerings.

What is ETON known for?

Snapshot

Public US

Ownership

2017

Year founded

Employees

Illinois, United States

Head office

Loading Map...

Operations

All Locations

United States

Products and/or services of Eton Pharmaceuticals

Alkindi Sprinkle, a hydrocortisone oral granules product for pediatric adrenal insufficiency, offers precise dosing for children.
Biorphen, the first and only FDA-approved ready-to-use formulation of phenylephrine injection, addresses critical care needs in hypotension during anesthesia.
Carglumic Acid, an essential treatment for hyperammonemia due to N-acetylglutamate synthase deficiency, providing life-saving care.
Dehydrated Alcohol Injection, a critical tool for therapeutic neurolysis in pain management, offering specialized treatment options.
Zeneo Hydrocortisone Autoinjector under development, aims for rapid administration in adrenal crisis, enhancing patient safety.
DS-100, an ophthalmic solution project, focuses on innovative delivery systems for eye diseases, promising advanced eye care solutions.